Home
/
RHYTHM PHARMACEUTICALS, INC.
/
Financials
/
Quarterly
RHYTHM PHARMACEUTICALS, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that RHYTHM PHARMACEUTICALS, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$51.30M
Nov 4, 2025
Q2
2025
Jun 30, 2025
$48.50M
Aug 5, 2025
Q1
2025
Mar 31, 2025
$32.70M
May 7, 2025
Q3
2025
Sep 30, 2024
$33.25M
Nov 4, 2025
Q2
2025
Jun 30, 2024
$29.08M
Aug 5, 2025
Q1
2025
Mar 31, 2024
$25.97M
May 7, 2025
Q3
2024
Sep 30, 2023
$22.50M
Nov 6, 2024
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($52.90M)
Nov 4, 2025
Q3
2025
Jun 30, 2025
($46.63M)
Nov 4, 2025
Q2
2025
Jun 30, 2025
($46.63M)
Aug 5, 2025
Q2
2025
Mar 31, 2025
($49.50M)
Aug 5, 2025
Q1
2025
Mar 31, 2025
($49.50M)
May 7, 2025
Q3
2025
Mar 31, 2025
($49.50M)
Nov 4, 2025
Q3
2025
Sep 30, 2024
($43.64M)
Nov 4, 2025
Q2
2025
Jun 30, 2024
($32.26M)
Aug 5, 2025
Q3
2025
Jun 30, 2024
($32.26M)
Nov 4, 2025
Q2
2025
Mar 31, 2024
($141.37M)
Aug 5, 2025
Q3
2025
Mar 31, 2024
($141.37M)
Nov 4, 2025
Q1
2025
Mar 31, 2024
($141.37M)
May 7, 2025
Q3
2024
Sep 30, 2023
($44.16M)
Nov 6, 2024
Q3
2024
Jun 30, 2023
($46.70M)
Nov 6, 2024
Q2
2024
Jun 30, 2023
($46.70M)
Aug 6, 2024
Q2
2024
Mar 31, 2023
($52.18M)
Aug 6, 2024
Q3
2024
Mar 31, 2023
($52.18M)
Nov 6, 2024
Q1
2024
Mar 31, 2023
($52.18M)
May 7, 2024
Q3
2023
Sep 30, 2022
($40.86M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($45.00M)
Aug 1, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($52.65M)
Nov 4, 2025
Q2
2025
Jun 30, 2025
($45.30M)
Aug 5, 2025
Q1
2025
Mar 31, 2025
($47.00M)
May 7, 2025
Q3
2025
Sep 30, 2024
($43.89M)
Nov 4, 2025
Q2
2025
Jun 30, 2024
($40.48M)
Aug 5, 2025
Q1
2025
Mar 31, 2024
($139.89M)
May 7, 2025
Q3
2024
Sep 30, 2023
($43.95M)
Nov 6, 2024
Q2
2024
Jun 30, 2023
($46.60M)
Aug 6, 2024
Q1
2024
Mar 31, 2023
($52.53M)
May 7, 2024
Q3
2023
Sep 30, 2022
($39.27M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($45.10M)
Aug 1, 2023
Q1
2023
Mar 31, 2022
($52.69M)
May 2, 2023
Q3
2022
Sep 30, 2021
($44.24M)
Nov 8, 2022
Q2
2022
Jun 30, 2021
($40.43M)
Aug 3, 2022
Q1
2022
Mar 31, 2021
($34.40M)
May 3, 2022
Q3
2021
Sep 30, 2020
($34.28M)
Nov 2, 2021
Q2
2021
Jun 30, 2020
($31.92M)
Aug 3, 2021
Q1
2021
Mar 31, 2020
($35.30M)
May 3, 2021
Q3
2020
Sep 30, 2019
($37.11M)
Nov 2, 2020
Q2
2020
Jun 30, 2019
($44.15M)
Aug 3, 2020